Quinn Opportunity Partners LLC Paratek Pharmaceuticals, Inc. Transaction History

Quinn Opportunity Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$2.67 - $4.97 $70,589 - $131,396	-26,438 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$2.93 - $4.5 $152,360 - $234,000	-52,000 Reduced 66.29%	26,438 $107,000
Q3 2019 Nov 14, 2019	BUY	$3.08 - $5.76 $30,800 - $57,600	10,000 Added 14.61%	78,438 $339,000
Q1 2019 May 07, 2019	SELL	$5.36 - $7.24 $98,002 - $132,376	-18,284 Reduced 21.08%	68,438 $367,000
Q4 2018 Feb 13, 2019	BUY	$4.8 - $11.6 $92,563 - $223,694	19,284 Added 28.6%	86,722 $445,000
Q3 2018 Nov 14, 2018	BUY	$9.05 - $10.95 $90,500 - $109,500	10,000 Added 17.41%	67,438 $654,000
Q1 2018 May 14, 2018	BUY	$12.65 - $18.85 $726,590 - $1.08 Million	57,438 New	57,438 $747,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Quinn Opportunity Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Quinn Opportunity Partners LLC with notifications on news.